Form 4: Surrozen CFO Andrew Maleki Acquires Shares via ESPP
Statement of Changes in Beneficial Ownership
Surrozen, Inc. Chief Financial Officer Andrew Pedrum Maleki acquired 607 shares of common stock through the company's Employee Stock Purchase Plan.
Summary
- CFO Andrew Pedrum Maleki acquired 607 shares of Surrozen, Inc. (SRZN) common stock.
- The transaction occurred on June 15, 2026, at a price of $19.01 per share.
- The acquisition was made pursuant to the Surrozen, Inc. 2021 Employee Stock Purchase Plan (ESPP).
- Following this transaction, the reporting person holds 607 shares directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard, non-discretionary executive participation in an employee benefit plan.
Positives
- Insider participation in the company's Employee Stock Purchase Plan demonstrates alignment between management and shareholder interests.
Negatives
- None identified.
Risks
- None identified.
Future Outlook
No forward-looking guidance provided in this filing.
Management Comments
- The reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Industry Context
StockSavvy.ai notes that routine ESPP acquisitions by executives are standard corporate practice and generally reflect internal confidence in the company's long-term equity value rather than a signal of immediate market sentiment.
Comparison to Industry Standards
- The use of ESPPs is a standard compensation and retention tool across the biotechnology and pharmaceutical sectors.
- The transaction size is consistent with typical executive participation levels in employee stock purchase programs.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine internal equity acquisition.
Next Steps
- None mentioned.
Key Dates
| Date | Description |
|---|---|
| 06/15/2026 | Date of the share acquisition transaction. |
| 06/16/2026 | Date of the filing signature. |
Keywords
Surrozen, SRZN, Insider Trading, Form 4, ESPP, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.